Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesTandem Diabetes Care Inc

Tandem Diabetes Care Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
17.88 USD -0.89 ( 4.74%)
Last update at 2026-11-12T15:49:00Z
VOLUME
366174
Market Cap
1537.29M

Momentum Score

…

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
17.77
Low
19.20
High
52 Week Price Range
15.75
Low
53.69
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Tandem Diabetes Care designs and sells insulin pumps, software and related diabetes-management systems for people with insulin-dependent diabetes, operating in the medical devices and digital health industry. Long-term growth may be supported by rising AID (automated insulin delivery) adoption, ongoing integration with continuous glucose monitors, software-upgrade revenue and international expansion, which could support continued market share gains.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
18.77
Dividend Yield
-
Revenue TTM
982.95M
Revenue Per Share
14.96
Gross Profit TTM
513.31M
Debt / Equity
1.80
ROE
-92.31%
Net Debt
404.33M
ROCE
-8.58%
Diluted EPS TTM
-2.79

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -92.85M 15.90M -36.28M -24.60M -122.56M
Net income -94.59M 15.57M -34.38M -24.75M -122.61M
Selling general administrative 335.68M 261.51M 204.90M 165.74M 105.23M
Gross profit 412.99M 376.21M 260.52M 194.21M 89.82M
Reconciled depreciation 14.33M 13.85M 10.45M 6.07M 5.82M
Ebit -61.81M 8.81M -18.41M -22.79M -50.45M
Ebitda -30.77M 22.65M -7.96M -16.72M -44.63M
Depreciation and amortization 31.04M 13.85M 10.45M 6.07M 5.82M
Non operating income net other -0.00M -6.75M -28.32M -7.88M -77.93M
Operating income -61.81M 8.81M -7.96M -16.72M -44.63M
Other operating expenses 863.03M 680.15M 506.79M 379.03M 228.50M
Interest expense 4.31M 4.31M 12.15M 0.08M 7.58M
Tax provision 1.74M 0.34M -1.90M 0.15M 0.05M
Interest income 6.06M 0.67M 1.57M 3.27M 1.46M
Net interest income -0.15M -5.37M -11.24M 3.19M -6.12M
Non recurring 31.04M - - - -
Income tax expense 1.74M 0.34M -1.90M 0.15M 0.05M
Total revenue 801.22M 702.80M 498.83M 362.31M 183.87M
Total operating expenses 474.80M 353.56M 268.48M 210.93M 134.45M
Cost of revenue 388.23M 326.58M 238.31M 168.09M 94.04M
Total other income expense net -31.04M 7.09M -28.32M -7.88M -77.93M
Net income from continuing ops -94.59M 15.57M -34.38M -24.75M -122.61M
Net income applicable to common shares -94.59M 15.57M -34.38M -24.75M -122.61M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 967.66M 952.66M 1052.79M 905.14M 716.41M
Intangible assets 0.93M 2.78M 4.63M 6.64M 8.80M
Other current assets 21.96M 16.59M 7.24M 8.43M 6.38M
Total liab 704.56M 639.03M 612.84M 472.02M 350.11M
Total stockholder equity 263.10M 313.63M 439.95M 433.11M 366.31M
Other current liab 149.82M 84.62M 77.60M 84.36M 70.54M
Common stock 0.07M 0.07M 0.07M 0.06M 0.06M
Capital stock 0.07M 0.07M 0.07M 0.06M 0.06M
Retained earnings -1047.83M -951.80M -729.19M -634.60M -659.21M
Other liab - - 36.09M 34.78M 27.36M
Other assets - - 10.70M 9.09M 29.16M
Cash 69.23M 58.87M 172.52M 71.18M 94.61M
Total current liabilities 247.05M 195.26M 165.29M 131.86M 103.85M
Current deferred revenue 11.83M 43.99M 18.84M 10.18M 6.08M
Net debt 404.33M 356.80M 247.36M 243.49M 133.71M
Short term debt 40.67M 17.06M 13.12M 9.28M 9.42M
Short long term debt 40.67M - - - -
Short long term debt total 473.56M 415.67M 419.88M 314.67M 228.32M
Other stockholder equity 1312.80M 1264.00M 1170.89M 1068.26M 1025.23M
Property plant equipment - - 68.55M 50.39M 50.02M
Total current assets 724.49M 747.99M 849.98M 811.52M 637.24M
Long term investments 74.55M - - - -
Net tangible assets - - 439.95M 433.11M 366.31M
Short term investments 369.10M 409.04M 444.38M 552.63M 390.32M
Net receivables 114.58M 105.56M 114.72M 110.72M 82.19M
Long term debt 308.27M 285.04M 283.23M 281.47M 202.98M
Inventory 149.61M 157.94M 111.12M 68.55M 63.72M
Accounts payable 44.73M 49.59M 55.73M 28.03M 17.80M
Accumulated other comprehensive income -1.95M 1.37M -1.82M -0.62M 0.22M
Common stock total equity - - 0.07M 0.06M 14.26M
Retained earnings total equity - - -729.19M -634.60M -659.21M
Non currrent assets other 4.24M 37.56M 19.00M 9.09M 0.58M
Non current assets total 243.17M 204.67M 202.81M 93.62M 79.18M
Capital lease obligations 124.63M 130.63M 136.65M 33.20M 25.34M
Long term debt total - - - 281.47M 202.98M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 33.17M -163.37M -263.76M -37.41M -87.75M
Change to liabilities 13.10M 33.73M 12.88M 28.90M 17.87M
Total cashflows from investing activities 33.17M -186.88M -296.06M -56.95M -90.74M
Net borrowings - - 278.69M 278.69M -87.71M
Total cash from financing activities 16.88M 51.93M 314.44M 24.21M 117.18M
Change to operating activities 12.78M 29.42M 9.46M 18.82M 13.84M
Net income -94.59M 15.57M -34.38M -24.75M -122.61M
Change in cash 101.34M -23.43M 43.44M 9.35M 18.13M
Begin period cash flow 71.18M 94.61M 51.17M 41.83M 23.70M
End period cash flow 172.52M 71.18M 94.61M 51.17M 41.83M
Total cash from operating activities 50.46M 111.36M 24.67M 41.91M -8.32M
Issuance of capital stock - - 0.00M 0.00M 172.93M
Depreciation 14.33M 13.85M 10.45M 6.07M 5.82M
Other cashflows from investing activities -34.58M -9.33M -4.89M -37.41M -87.75M
Change to inventory -42.45M -4.95M -15.36M -30.98M 6.76M
Change to account receivables -7.83M -30.98M -38.84M -13.70M -15.85M
Sale purchase of stock 17.55M 51.93M 69.82M 24.21M 31.97M
Other cashflows from financing activities -0.59M 0.59M 247.57M 0.33M 31.97M
Change to netincome 121.73M 65.48M 76.39M 73.50M 97.75M
Capital expenditures 42.95M 23.51M 32.29M 19.54M 2.99M
Change receivables -7.83M -30.98M -38.84M -13.70M -15.85M
Cash flows other operating 40.10M 16.57M 4.73M 3.42M -0.31M
Cash and cash equivalents changes 100.51M -23.59M 43.05M 9.16M 18.13M
Change in working capital -4.65M 14.37M -36.59M -12.35M 8.46M
Stock based compensation 84.92M 60.75M 58.43M 58.07M 23.74M
Other non cash items 50.46M 2.27M 28.88M -0.32M 76.27M
Free cash flow 7.51M 87.85M -7.62M 22.36M -11.30M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TNDM
Tandem Diabetes Care Inc		 -0.89
4.74%		 17.88 - 1111.11 1.56 9.90 1.69 -10.72
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

12400 High Bluff Drive, San Diego, CA, United States, 92130

858 366 6900

https://www.tandemdiabetes.com

2650

Name Title Year Born
Mr. John F. Sheridan Pres, CEO & Director 1955
Ms. Leigh A. Vosseller Exec. VP, CFO & Treasurer 1973
Mr. David B. Berger Esq. Exec. VP & COO 1970
Ms. Susan M. Morrison Exec. VP & Chief Admin. Officer 1979
Mr. Brian B. Hansen Exec. VP & Chief Commercial Officer 1968
Ms. Elizabeth Anne Gasser Exec. VP & Chief Strategy Officer 1976
Mr. Rick A. Carpenter Chief Technical Officer 1963
Ms. Shannon M. Hansen Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. 1966
Mr. Ross Sylvia VP of Marketing NA
Mr. Tom Fox Sr. VP of HR & Organizational Devel. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…